BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31583704)

  • 1. Endoscopy for gastroesophageal reflux disease and survival in esophageal adenocarcinoma.
    Holmberg D; Ness-Jensen E; Mattsson F; Lagergren J
    Int J Cancer; 2020 Jul; 147(1):93-99. PubMed ID: 31583704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
    Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
    Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants.
    Mäntynen T; Färkkilä M; Kunnamo I; Mecklin JP; Juhola M; Voutilainen M
    Am J Gastroenterol; 2002 Oct; 97(10):2524-9. PubMed ID: 12385433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and Mortality in Upper Gastrointestinal Cancer After Negative Endoscopy for Gastroesophageal Reflux Disease.
    Holmberg D; Santoni G; von Euler-Chelpin MC; Färkkilä M; Kauppila JH; Maret-Ouda J; Ness-Jensen E; Lagergren J
    Gastroenterology; 2022 Feb; 162(2):431-438.e4. PubMed ID: 34627859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus.
    El-Serag HB; Naik AD; Duan Z; Shakhatreh M; Helm A; Pathak A; Hinojosa-Lindsey M; Hou J; Nguyen T; Chen J; Kramer JR
    Gut; 2016 Aug; 65(8):1252-60. PubMed ID: 26311716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans.
    Rubenstein JH; Sonnenberg A; Davis J; McMahon L; Inadomi JM
    Gastrointest Endosc; 2008 Nov; 68(5):849-55. PubMed ID: 18547567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal Adenocarcinoma After Antireflux Surgery in a Cohort Study From the 5 Nordic Countries.
    Maret-Ouda J; Santoni G; Wahlin K; Artama M; Brusselaers N; Färkkilä M; Lynge E; Mattsson F; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
    Ann Surg; 2021 Dec; 274(6):e535-e540. PubMed ID: 31800492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries.
    Maret-Ouda J; Wahlin K; Artama M; Brusselaers N; Färkkilä M; Lynge E; Mattsson F; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
    JAMA Oncol; 2018 Nov; 4(11):1576-1582. PubMed ID: 30422249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.
    Voutilainen M; Sipponen P; Mecklin JP; Juhola M; Färkkilä M
    Digestion; 2000; 61(1):6-13. PubMed ID: 10671769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of upper gastrointestinal cancers in patients with gastroesophageal reflux disease after a negative screening endoscopy.
    Shakhatreh MH; Duan Z; Avila N; Naik AD; Kramer JR; Hinojosa-Lindsey M; Chen J; El-Serag HB
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):280-6. PubMed ID: 25004461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
    Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
    Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma.
    Renouf DJ; Zhai R; Sun B; Xu W; Cheung WY; Heist RS; Kulke MH; Cescon D; Asomaning K; Marshall AL; Li S; Christiani DC; Liu G
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1482-8. PubMed ID: 23735059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma.
    Hammad TA; Thrift AP; El-Serag HB; Husain NS
    Dig Dis Sci; 2019 Feb; 64(2):367-372. PubMed ID: 30370493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroesophageal reflux does not alter effects of body mass index on risk of esophageal adenocarcinoma.
    Lagergren J; Mattsson F; Nyrén O
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):45-51. PubMed ID: 23920035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett's Esophagus With a Minimally Invasive Cell Sampling Device.
    Heberle CR; Omidvari AH; Ali A; Kroep S; Kong CY; Inadomi JM; Rubenstein JH; Tramontano AC; Dowling EC; Hazelton WD; Luebeck EG; Lansdorp-Vogelaar I; Hur C
    Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1397-1404.e7. PubMed ID: 28238953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor A61G gene polymorphism, gastroesophageal reflux disease and esophageal adenocarcinoma risk.
    Cheung WY; Zhai R; Kulke MH; Heist RS; Asomaning K; Ma C; Wang Z; Su L; Lanuti M; Tanabe KK; Christiani DC; Liu G
    Carcinogenesis; 2009 Aug; 30(8):1363-7. PubMed ID: 19520791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome.
    Lanuti M; Liu G; Goodwin JM; Zhai R; Fuchs BC; Asomaning K; Su L; Nishioka NS; Tanabe KK; Christiani DC
    Clin Cancer Res; 2008 May; 14(10):3216-22. PubMed ID: 18483390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphisms in the matrix metalloproteinase gene family and the frequency and duration of gastroesophageal reflux disease influence the risk of esophageal adenocarcinoma.
    Cheung WY; Zhai R; Bradbury P; Hopkins J; Kulke MH; Heist RS; Asomaning K; Ma C; Xu W; Wang Z; Hooshmand S; Su L; Christiani DC; Liu G
    Int J Cancer; 2012 Dec; 131(11):2478-86. PubMed ID: 22422400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-cardiac chest pain: the long-term natural history and comparison with gastroesophageal reflux disease.
    Williams JF; Sontag SJ; Schnell T; Leya J
    Am J Gastroenterol; 2009 Sep; 104(9):2145-52. PubMed ID: 19513020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Any role for endoscopy screening or surveillance for esophageal adenocarcinoma among persons with GERD?
    Lagergren J
    Gastrointest Endosc; 2008 Nov; 68(5):856-8. PubMed ID: 18984099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.